Date : 24 July 2026
Format : Physical & Online
Venue : LT5 & LT6, Yasumoto International Academic Park, The Chinese University of Hong Kong
Themes : International Conference on Cancer Prevention and Treatment via Traditional Chinese Medicine: From Basic Research to Clinical Translation
Official Language : English






WELCOME MESSAGE FROM THE CONFERENCE CHAIRPERSON

On behalf of the Organizing Committee, we would like to warmly welcome you to the "International Conference on Cancer Prevention and Treatment via Traditional Chinese Medicine: From Basic Research to Clinical Translation" (中醫藥防治腫瘤國際會議:從基礎研究到臨床轉化) to be held on 24 July, 2026 in Hong Kong.

We are gathered here at a pivotal moment, as the global community seeks integrative and holistic approaches to combat cancer. This conference serves as a vital platform to bridge the Traditional Chinese Medicine (TCM) with the rigorous methodologies of modern science. Our goal is to foster a dynamic dialogue that traverses the entire spectrum of discovery—from unraveling fundamental mechanisms at the bench to implementing effective, evidence-based strategies at the bedside.

In this conference, we will delve into groundbreaking basic research, explore innovative clinical trials, and discuss the challenges and opportunities in translating TCM principles into mainstream oncology practice. We are privileged to have with us a distinguished assembly of world-renowned scientists, clinicians, and researchers who will share their invaluable insights and pioneering work.

We encourage you to engage actively, forge new collaborations, and challenge existing paradigms. It is through this shared commitment to knowledge and healing that we can unlock the full potential of TCM in the global fight against cancer.

We hope all of you will find this Conference a rewarding and enjoyable experience.



REGISTRATION

All registration must be made online and it's free of charge.
Registration period: from now to 1 July 2026





SPEAKERS
(As of mid-January 2026; in alphabetic order)

Keynote Speakers

Prof. Zhe-Sheng CHEN
Professor and Director, Institute for Biotechnology, St. John's University
Prof. Thomas Efferth
Chair, Department of Pharmaceutical Biology, Johannes Gutenberg University
Prof. Lizhu LIN
Professor, The First Clinical Medical School of Guangzhou University of Chinese Medicine
Director, Cancer Center of The First Affiliated Hospital to Guangzhou University of Chinese Medicine
Prof. Di ZHU
Professor, School of Basic Medical Sciences, Fudan University


Invited Speakers

Prof. Chunhui JIN
Professor, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine
Prof. Yuan Ma
Research Assistant Professor, School of Chinese Medicine, The Chinese University of Hong Kong
Prof. Jianlin REN
Professor, Shanghai Hospital of Traditional Chinese Medicine
Dr. Weiwei TANG
Associate research fellow, Jiangsu Province Hospital
Prof. Jian Hui TIAN
Director of the Cancer Research Institute of Shanghai Hospital of Traditional Chinese Medicine
Distinguished Professor of Shanghai University of Traditional Chinese Medicine
Prof. Junjian WANG
Professor, School of Pharmaceutical Sciences, Sun Yat-sen University
Prof. Qi WANG
Professor, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine
Prof. Yanfang XIAN
Assistant Professor, School of Chinese Medicine, The Chinese University of Hong Kong
Dr. Yu XU
Associate Chief Physician, Fudan University Shanghai Cancer Center
Prof. Ming Zhao
Professor, Nanjing University of Chinese Medicine




PROGRAMME RUNDOWN

24 JULY 2026 (Friday)
Time 時間 Programme 程序
08:30 a.m.- 09:00 a.m Registration 登記
09:00 a.m. – 09:30 a.m. Opening Ceremony 開幕典禮
09:30 a.m. – 10:20 a.m. Keynote Lecture: Beyond Single Targets: Network Pharmacology and AI in the Era of Complex Disease Treatment

Prof. Thomas Efferth
Chair, Department of Pharmaceutical Biology, Johannes Gutenberg University/ Editor-in-chief of Phytomedicine
托馬斯·埃弗斯教授
約翰內斯古騰堡大學藥物生物學系主任/ 《Phytomedicine》主編
10:20 a.m. – 11:10 a.m. Keynote Lecture :Methyl-cantharidimide suppresses cyclin-dependent kinase 1 (CDK1) and induces oxeiptosis in liver cancer

Prof. Zhe-Sheng CHEN
Director, Institute for Biotechnology, St. John's University
陳哲生教授
聖約翰大學生物技術研究所所長
11:10 a.m. – 11:20 a.m. Tea Break & Poster Viewing
茶歇及海報展示
11:20 a.m. – 12:10 a.m. Keynote Lecture : The contributions of Traditional Chinese Medicine to human health from the perspective of the history of oncology of Traditional Chinese Medicine
從中醫腫瘤發展史看中醫藥對人類健康的貢獻

Prof. Lizhu LIN
Director, Cancer Center of The First Affiliated Hospital to Guangzhou University of Chinese Medicine
林麗珠教授
廣州中醫藥大學第一附屬醫院腫瘤中心主任
12:10 a.m. – 01:30 p.m. Lunch 午膳
Parallel Session 分論壇
  Session 1:
Basic Research on TCM in Cancer Prevention and Treatment
中醫藥在癌症防治的基礎研究
Moderators 主持: 待定
Session 2:
Clinical Translation of TCM in Cancer Prevention and Treatment
中醫藥在癌症防治的臨床研究轉化
Moderators 主持:待定
01:30 p.m. – 01:55 p.m. Troxerutin suppresses the stemness of hepatocellular carcinoma via the Syk/FOXO3 feedback loop

Prof. Qi WANG
Professor, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine
王奇教授
廣州中醫藥大學科技創新中心教授
Establishment and Application of the “Regulating Spirit to Treat Cancer” Theory: An Integrative Study Based on Tumor Immune Microenvironment
調神治癌理論的創建與應用:基於腫瘤免疫微環境的中醫整合醫學研究

Prof. Jian Hui TIAN
Director of the Cancer Research Institute of Shanghai Hospital of Traditional Chinese Medicine
Distinguished Professor of Shanghai University of Traditional Chinese Medicine
田建輝教授
上海市中醫醫院腫瘤臨床醫學中心主任/腫瘤研究所所長,上海中醫藥大學特聘教授
01:55 p.m. – 02:20 p.m. Targeting Nuclear Receptors for Drug Discovery and Cancer Therapy

Prof. Junjian WANG
Professor, School of Pharmaceutical Sciences, Sun Yat-sen University
王軍艦教授
中山大學藥學院教授
Academic Insights into Professor Zhao Jingfang’s “Fine-Tuning Balance Method” for Treating Malignant Tumors: Theoretical Framework and Related Research
全國名老中醫趙景芳教授「微調平衡法」治療惡性腫瘤的學術思想及相關研究

Prof. Chunhui JIN
Professor, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine
金春暉教授
國家中醫優勢專科無錫市中醫醫院腫瘤科主任,學科帶頭人
02:20 p.m. – 02:45 p.m. Dehydrocostus Lactone Inhibits Prostate Cancer Progression via Directly Targeting MB21D2
去氫木香內酯標靶MB21D2抗前列腺癌的發生與發展

Prof. Yanfang XIAN
Assistant Professor, School of Chinese Medicine, The Chinese University of Hong Kong
冼彥芳教授
香港中文大學中醫學院助理教授
Exploring Traditional Chinese Medicine Treatment and Its Clinical Translational Research in Colorectal Cancer Based on the Theory of Spleen Deficiency and Collateral Stasis
基於脾虛絡瘀理論探討大腸直腸癌的中醫治療及其臨床轉化研究

Prof. Jianlin REN
Professor, Shanghai Hospital of Traditional Chinese Medicine
任建琳教授
上海市中醫醫院內科主任
02:45 p.m. – 03:10 p.m. Anti-pancreatic Cancer Effects and Mechanisms of Quassinoid from Fructus Bruceae via Regulation of the Tumor Microenvironment
中藥鴉膽子苦木素類成分調控腫瘤微環境抗胰臟癌的作用與機制

Prof. Ming Zhao
Professor, Nanjing University of Chinese Medicine
趙明教授
南京中醫藥大學教授 藥學院院長
Treatment Advances in Acral and Mucosal Melanoma: Chinese Experience
支端和黏膜黑色素瘤的治療進展:中國經驗

Dr. Yu XU
Associate Chief Physician, Fudan University Shanghai Cancer Center
徐宇主任
復旦大學附屬腫瘤醫院骨軟組織外科副主任醫師
03:15 p.m. – 03:35 p.m. Tumor Progression and Metastasis and Serves as a Therapeutic Target in Triple-Negative Breast Cancer
細胞內硬骨抑素蛋白促進腫瘤進展與轉移並作為三陰性乳癌的治療標靶

Prof. Yuan Ma
Research Assistant Professor, School of Chinese Medicine, The Chinese University of Hong Kong
馬元教授
香港中文大學中醫學院研究助理教授
From Molecule to Cosmos: Decoding the Wisdom of Traditional Chinese Medicine in the Era of Precision Oncology
從分子到宇宙-精準腫瘤學時代下中醫藥智慧的現代解碼

Dr. Weiwei TANG
Associate research fellow, Jiangsu Province Hospital
唐薇薇研究員
南京醫科大學第一附屬醫院肝膽中心研究員
03:35 p.m. – 04:00 p.m. Panel discussion
分論壇討論
Panel discussion
分論壇討論
04:00 p.m. – 04:20 p.m. Tea Break & Poster Viewing 茶歇&海報展示
04:20 p.m. – 05:10 p.m. Keynote Lecture : Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation
克服免疫治療耐藥:靶向BCL9啟動巨噬細胞吞噬及抗原呈遞協同抗腫瘤免疫

Prof. Di ZHU
Professor, School of Basic Medical Sciences, Fudan University
朱棣教授
復旦大學特聘教授
05:10 p.m. – 05:30 p.m. Poster Award Presentation & Closing Ceremony 海報獎頒獎典禮及閉幕式




ORGANIZER

School of Chinese Medicine, The Chinese University of Hong Kong



CO-ORGANIZERS

  • The Chinese University of Hong Kong Chinese Medicine Specialty Clinic cum Clinical Teaching and Research Centre
  • The Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong
  • Li Dak Sum Yip Yio Chin R&D Centre for Chinese Medicine, The Chinese University of Hong Kong
  • School of Chinese Medicine, The University of Hong Kong
  • Hong Kong Association for Integration of Chinese-Western Medicine
  • Law Sau Fai Institute For Advancing Translational Medicine in Bone & Joint Diseases, Hong Kong Baptist University (To be confirmed)
  • School of Chinese Medicine, Hong Kong Baptist University
  • Shenzhen Research Instituite ,The Chinese University of Hong Kong



    ORGANIZING COMMITTEE

    Chairperson

    Prof. Zhi-Xiu LIN (林志秀教授)
    Director and Professor, School of Chinese Medicine, The Chinese University of Hong Kong
    Director, The Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong

    Co-Chairperson

    Prof. Baoting ZHANG (張保亭教授)
    Associate Director and Professor, School of Chinese Medicine, The Chinese University of Hong Kong

    Members

    Prof. XU Hongxi XU (徐宏喜教授)
    Distinguished Professor and Honorary Dean, School of Pharmacy, Shanghai University of Traditional Chinese Medicine

    Prof. Yibin FENG (馮奕斌教授)
    Professor, School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong

    Prof. Ge ZHANG (張戈教授)
    Professor and Associate Dean (Research), School of Chinese Medicine, Hong Kong Baptist University

    Prof. Min Li (李敏教授)
    Dean and Chair Professor, School of Chinese Medicine, Hong Kong Baptist University

    Prof. Yanfang XIAN (冼彥芳教授)
    Assistant Professor, School of Chinese Medicine, The Chinese University of Hong Kong

    Prof. Zongkang ZHANG (張宗康教授)
    Assistant Professor, School of Chinese Medicine, The Chinese University of Hong Kong

    Prof. Yuan MA (馬元教授)
    Research Assistant Professor, School of Chinese Medicine, The Chinese University of Hong Kong

    Dr. Ching LIONG (梁晶博士)
    Professional Consultant and Head, Clinical Division, School of Chinese Medicine, The Chinese University of Hong Kong



    CME ACCREDITATION

    * CME accreditation is applicable to Hong Kong Registered Chinese Medicine Practitioners only.
      CME code: CME PP0018 SCM0522

    * Participant must attend a complete session to earn the 6 CME points. All CME certificates will be available to download after the end of the session. Once the registration is admitted, participant cannot transfer the registration to others (If found, we have the right to cancel the concerned CME certificate). Late for 30 minutes or more will be considered as absent, the CME certificate for the session will not be issued for the participant. A non-refundable administration fee of HK$60 will be charged for each application.

    * Complete session: 24 July 2026: 9:05a.m. - 12:20 p.m. and 1:39 p.m. to 5:40 p.m.



    CALL FOR ABSTRACT

    Abstract submission will be open until 1 June 2026.

  • Abstract Submission Form Sample Format
  • Go to Abstract and Poster Submission System

    Submission Guideline:
    1. Please complete the Abstract Submission Form and upload via the Abstract and Poster Submission System. Submission via other methods will not be accepted.
    2. Author could submit more than one abstract, but the author has to use a NEW form for every abstract.
    3. Submitted material is original work and has not been previously published
    4. All abstracts must be submitted in ENGLISH and word limit is 500 words including acknowledgement. No table and picture is allowed.
    5. Please make sure all information is properly filled in. No amendment is allowed after the abstract has been submitted
    6. Abstract submission form should be submitted in Microsoft Word format.
    7. Selected abstracts will be invited for a poster presentation and published in the conference program book.
    8. Once an abstract has been submitted, a confirmation e-mail will be sent to all authors within 2 working days. Please notify conference secretariat via email (iccpt@cuhk.edu.hk) in case confirmation e-mail is not received.
    9. Notification of abstract acceptance/rejection will be made on or before 1 July 2026 via email.
    10. Presenting author of accepted abstracts must register for the conference.
    11. Poster Presentation Competition: The Conference Committee will select the best posters and the best investigators. Each winner will be awarded a certificate and HK$500 cash. The winning results will be announced during the conference.
    Instructions for e-Poster Presentation:
    1. Please upload the poster via the Abstract and Poster Submission System. Submission via other methods will not be accepted.
    2. Layout: Portrait (vertical orientation); Single-page
    3. File Format: PDF Format ONLY
    4. Media: Images, photos, graphs and tables can be included in the e-poster
    5. Poster Size:
      - In pixels: 1080 width x 1536 height
      - In cm: 38.1 width x 54.2 height
    6. Picture / Graphs: No smaller than 200 dpi
    7. File Size: Maximum 15 Megabytes (15MB)
    8. Restrictions: Do not include any audio or videos in the e-poster
    Enquiries:

       Conference Secretariat
       School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR
       Tel: (852) 3943 9259
       Email: iccpt@cuhk.edu.hk



    DISCLAIMER
    1. The personal data collected will be used by School of Chinese Medicine, The Chinese University of Hong Kong and the authorized personnel for processing captioned purposes only. All personal data you provided will not be disclosed to any third parties except as required by law or with your prior consent.
    2. Any opinions, research, findings, conclusions or recommendations expressed in this material/event (or by the grantee) do not reflect the views or opinions of the Government of the Hong Kong Special Administrative Region, the Health Bureau, the Advisory Committee on Chinese Medicine Development Fund, the Implementation Agent of the Chinese Medicine Development Fund or the Hong Kong Productivity Council.






  • Copyright ©2026 School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong. All Rights Reserved.